Alex Wong is an Associate at F-Prime Capital and works across the healthcare sub-sectors including Therapeutics, MedTech, and Healthcare IT and Services, and also closely with the Eight Roads Ventures China team to manage F-Prime’s existing and new investment efforts in China. Prior to F-Prime, Alex was a healthcare strategy consultant with Analysis Group, where he advised biotech and pharmaceutical companies on value proposition strategy, pricing/market access, and health economics/outcomes research.

Alex received his B.A. in Biology and Economics from the University of Pennsylvania.